Ticagrelor, 98%

Name: Ticagrelor, 98% | 274693-27-5
Brand: J&K Chemical
SKU: JK968233_25_MG
Price: 228.0 USD
Availability: InStock

Cat. No JK968233_25_MG

Vendor: J&K Chemical

Product Information

Product Name

Ticagrelor, 98%

Brand Name

J&K

Product Number

968233

CAS

274693-27-5

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

9871419

IUPAC Name

(1S,2S,3R,5S)-3-7-(1R,2S)-2-(3,4-difluorophenyl)cyclopropylamino-5-propylsulfanyltriazolo4,5-dpyrimidin-3-yl-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

InChI Key

OEKWJQXRCDYSHL-FNOIDJSQSA-N

SMILES

CCCSC1=NC(=C2C(=N1)N(N=N2)C@@H3CC@@H(C@H(C@H3O)O)OCCO)NC@@H4CC@H4C5=CC(=C(C=C5)F)F

Safety Information

Storage Condition

Store at 2-8℃

References Data Source From Pubchem

Early vascular healing after neXt-generation drug-eluting stent implantation in Patients with non-ST elevation acute Coronary syndrome: a randomized optical coherence Tomography imaging study (EXPECT)

Publication Name: The International Journal of Cardiovascular Imaging

Publication Date: 2026-04

DOI: 10.1007/s10554-024-03258-w

Mid- and Long-Term Outcomes Following Flow Diversion for Carotid-Ophthalmic Aneurysms: a Single-Centre Experience

Publication Name: Clinical Neuroradiology

Publication Date: 2026-03-04

DOI: 10.1007/s00062-026-01625-9

Revisiting ischemic and bleeding events in high bleeding risk patients after PCI: insights from a Japanese nationwide registry

Publication Name: Cardiovascular Intervention and Therapeutics

Publication Date: 2026-03-03

DOI: 10.1007/s12928-026-01247-5

[48/m with hematemesis : Preparation for the medical specialist examination: part 22]

Publication Name: Medizinische Klinik, Intensivmedizin und Notfallmedizin

Publication Date: 2026-03

DOI: 10.1007/s00063-025-01405-2

[58/m with acute coronary syndrome : Preparation for the medical specialist examination: part 6]

Publication Name: Medizinische Klinik, Intensivmedizin und Notfallmedizin

Publication Date: 2026-03

DOI: 10.1007/s00063-025-01377-3

Ticagrelor, 98%

Product Information

General Information

Safety Information

References Data Source From Pubchem

Early vascular healing after neXt-generation drug-eluting stent implantation in Patients with non-ST elevation acute Coronary syndrome: a randomized optical coherence Tomography imaging study (EXPECT)

Mid- and Long-Term Outcomes Following Flow Diversion for Carotid-Ophthalmic Aneurysms: a Single-Centre Experience

Revisiting ischemic and bleeding events in high bleeding risk patients after PCI: insights from a Japanese nationwide registry

[48/m with hematemesis : Preparation for the medical specialist examination: part 22]

[58/m with acute coronary syndrome : Preparation for the medical specialist examination: part 6]

Ticagrelor, 98%

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Ticagrelor, 98%

Product Information

General Information

Safety Information

References Data Source From Pubchem

Early vascular healing after neXt-generation drug-eluting stent implantation in Patients with non-ST elevation acute Coronary syndrome: a randomized optical coherence Tomography imaging study (EXPECT)

Mid- and Long-Term Outcomes Following Flow Diversion for Carotid-Ophthalmic Aneurysms: a Single-Centre Experience

Revisiting ischemic and bleeding events in high bleeding risk patients after PCI: insights from a Japanese nationwide registry

[48/m with hematemesis : Preparation for the medical specialist examination: part 22]

[58/m with acute coronary syndrome : Preparation for the medical specialist examination: part 6]

Ticagrelor, 98%

Related Product

#title#

Login

Register